InterMune: Clinical Trials

3 trials sponsored by InterMune, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1
Phase 23Completed 2, Terminated 1

Follow InterMune: new trials by email

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients
Interferon Gamma-1b, Rituximab - Non-Hodgkin's Lymphoma
Phase 1 / Phase 2TerminatedInterMune242003-03-012007-11-01
Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis
interferon gamma-1b - Cystic Fibrosis
Phase 1 / Phase 2CompletedInterMune512002-04-012007-11-01
Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis
interferon gamma-1b - Cystic Fibrosis
Phase 1 / Phase 2CompletedInterMune662001-02-012007-11-01

Conditions studied

Cystic Fibrosis (2)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)

Interventions

interferon gamma-1b (3)  ·  Rituximab (1)

Countries

United States (2)

Top investigators

Steve Porter, MD (1)  ·  Steven Porter, MD (1)  ·  Williamson Bradford, MD (1)